Investigational drug · Phase 2
SR750
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Trigeminal Neuralgia.
Phase 2Last checked: Nov 19, 2026Latest source record: Apr 24, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
6
Any phase or sponsor naming "SR750"
First trial start
2024
Sep 16, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "SR750", any sponsor or status.
Conditions studied
As listed on its trial records.
- Trigeminal Neuralgia
Largest trials
Live from ClinicalTrials.gov: studies naming "SR750" as an intervention, largest first.
- Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal NeuralgiaPivotal-lookingCompleted
Shanghai SIMR Biotechnology Co., Ltd.Industry
NCT06571448 · 138 participants · Start Sep 16, 2024 · Primary completion Jan 26, 2026
Drug: SR750 tablet; SR750 tablet and 1 more · For: Trigeminal Neuralgia
Sites: Beijing, China
Shanghai SIMR Biotechnology Co., Ltd.Industry
NCT05083468 · 83 participants · Start Oct 29, 2021 · Primary completion Oct 14, 2022
Drug: SR750 tablet; matching placebo · For: Healthy Volunteers
Sites: Melbourne, Australia
Hanmi Pharmaceutical Company LimitedIndustry
NCT01929512 · 72 participants · Start Jun 2013 · Primary completion Aug 2013
Drug: HCP1201 750/20mg; Metformin SR 750mg and 1 more · For: Diabetes Mellitus
Sites: Seoul, South Korea
Shanghai SIMR Biotechnology Co., Ltd.Industry
NCT05753033 · 56 participants · Start Feb 28, 2023 · Primary completion Sep 6, 2023
Drug: SR750 tablet; Placebo · For: Healthy
Sites: Shanghai, China
- The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy VolunteersCompleted
Shanghai SIMR Biotechnology Co., Ltd.Industry
NCT06932536 · 40 participants · Start Apr 28, 2025 · Primary completion Jul 7, 2025
Drug: SR750 tablet; Placebo · For: Healthy
Sites: Shanghai, China
Hanmi Pharmaceutical Company LimitedIndustry
NCT02026817 · 36 participants · Start Dec 2013 · Primary completion Dec 2013
Drug: HCP1201 750/10mg; Metformin SR 750mg and 1 more · For: Diabetes Mellitus
Sites: Seoul, South Korea
Newest research
PubMed records naming it or its code names, newest first.
- [Leaf photosynthetic pigment seasonal dynamic of Quercus aliena var. acuteserrata and its spectral reflectance response under throughfall elimination].
Liu C, Sun PS, Liu SR, et al. · Ying Yong Sheng Tai Xue Bao 2017
- Histological comparison of two different fractional photothermolysis devices operating at 1,550 nm.
Thongsima S, Zurakowski D, Manstein D · Lasers Surg Med 2010
- Pilot investigation of the correlation between histological and clinical effects of infrared fractional resurfacing lasers.
Walgrave S, Zelickson B, Childs J, et al. · Dermatol Surg 2008
- Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation.
Ruiz-Rodriguez R, López L, Candelas D, et al. · J Drugs Dermatol 2007
Also in development for Trigeminal Neuralgia
- BasimglurantNOE-101Phase 32 trials
Noema Pharma AG · Trigeminal Neuralgia, Tuberous Sclerosis Complex
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.